Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases [PDF]
, 2003 Kari K. Eklund, Heikki Joensuu
openalex +1 more source
Fluorescence in situ hybridization for the BCR–ABL fusion gene in a patient with imatinib mesylate‐resistant chronic myelogenous leukaemia in extramedullary blast crisis [PDF]
, 2003 Takehiko Mori +3 more
openalex +1 more source
Dodging the Magic Bullet: Understanding Imatinib Resistance [PDF]
, 2003 George Q. Daley
openalex +1 more source
Ida‐FLAG plus imatinib mesylate‐induced molecular remission in a patient with chemoresistant Ph1(+) acute myeloid leukemia [PDF]
, 2003 Nora‐Athina Viniou +4 more
openalex +1 more source
The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase [PDF]
, 2003 Thomas B. Sneed +11 more
openalex +1 more source
BCR::ABL1‐Positive Acute Myeloid Leukemia
American Journal of Hematology, Volume 100, Issue 7, Page 1232-1233, July 2025.
Alban Canali +3 more
wiley +1 more source
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
Biologics: Targets & Therapy, 2009 Radhakrishnan Ramchandren, Charles A SchifferDivision of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USAAbstract: The development of imatinib for the treatment of chronic myeloid leukemia (CML ...
Radhakrishnan Ramchandren +1 more
doaj
Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era [PDF]
, 2003 Richard A. Van Etten
openalex +1 more source
Primary Management of Localized Gastrointestinal Stromal Tumors With Imatinib Monotherapy: An Alternative to Resection of Patients Precluded From Surgery. [PDF]
Clin Med Insights OncolWang JS +12 more
europepmc +1 more source